Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Quantum Computing

PUBLISHER: MarketsandMarkets | PRODUCT CODE: 1771315

Cover Image

PUBLISHER: MarketsandMarkets | PRODUCT CODE: 1771315

Quantum Computing in Healthcare Market by Component (Hardware, Software), Deployment (On-premises, Cloud-based), Technology (Superconducting Qubits, Trapped Ions), Application (Drug Discovery, Genomics), End User, and Region - Global Forecast to 2030

PUBLISHED:
PAGES: 294 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 4950
PDF (5-user License)
USD 6650
PDF (Corporate License)
USD 8150
PDF (Global License)
USD 10000

Add to Cart

Description

Table of Contents

List of Tables

The global quantum computing in healthcare market is projected to reach USD 1,324.2 million by 2030 from USD 265.9 million in 2025 at a high CAGR of 37.9% during the forecast period. The quantum computing market in healthcare is steadily advancing due to the pressing need to improve drug discovery, enhance clinical decision-making, and increase diagnostic accuracy. As healthcare data becomes more complex and voluminous, quantum computing offers powerful tools for simulation, modeling, and advanced data processing that surpass traditional systems. These solutions are expected to significantly reduce research timelines and costs while also facilitating the development of more targeted and personalized treatments.

Scope of the Report
Years Considered for the Study2023-2030
Base Year2024
Forecast Period2025-2030
Units ConsideredValue (USD Billion)
SegmentsComponent, Technology, Application, End User, Deployment, and Region
Regions coveredNorth America, Europe, Asia Pacific, Latin America, and the Middle East & Africa

The growth of this market is further supported by increasing funding for quantum startups, government-backed research initiatives, and collaborative efforts between academia and industry. However, the sector faces challenges, particularly regarding the accuracy of quantum systems and the high costs associated with their implementation, which continue to hinder widespread adoption.

"The superconducting qubits segment is expected to be the largest segment during the forecast period."

In 2024, superconducting qubits emerged as the largest segment in the quantum computing market for healthcare and are expected to maintain this position in the coming years. This dominance is driven by their maturity, scalability potential, and strong performance in executing complex computational tasks.

Superconducting qubit systems offer high-speed processing capabilities, making them well-suited for healthcare applications such as molecular simulations, genomic analysis, and drug discovery. These systems are also compatible with cloud-based quantum platforms, allowing researchers and clinicians broader access without the need for extensive on-premises infrastructure.

As the demand for more efficient tools to handle biomedical data and accurately model biological systems grows, superconducting qubit technology is increasingly being adopted in healthcare-focused quantum initiatives. Continued advancements in coherence times, error correction, and integration with hybrid computing frameworks further reinforce their role as a foundational technology for accelerating innovation in healthcare.

"Healthcare payers are expected to be the fastest-growing segment in the quantum computing in healthcare market, by end user, during the forecast period."

Healthcare payers have emerged as the fastest-growing end-user group in the quantum computing in healthcare market. This trend is driven by the increasing need for advanced data processing tools to manage healthcare costs, assess patient risks, and support personalized coverage plans. Quantum computing enables quicker analysis of complex datasets, allowing payers to enhance risk prediction, detect anomalies, and develop value-based reimbursement models. As the healthcare industry shifts toward data-driven decision-making, payers are adopting quantum technologies to improve operational efficiency, reduce fraud, and gain deeper insights into treatment outcomes and population health.

"Asia Pacific is expected to witness the highest growth rate during the forecast period."

The Asia Pacific region is projected to experience the fastest growth in the quantum computing in healthcare market during the forecast period. This growth is driven by increasing government support for quantum technology, a rise in research collaborations, and a surge in funding for emerging tech startups. Countries in the region are prioritizing quantum innovation through national strategies and investments, establishing a strong foundation for the application of these technologies in healthcare.

As the burden of chronic diseases grows, there is an increased focus on utilizing quantum computing for tasks such as drug research, genetic analysis, and complex data modeling. Additionally, enhanced digital infrastructure and wider access to cloud-based quantum platforms are facilitating faster adoption. Collectively, these factors are positioning Asia Pacific as a key hub for advancements in quantum healthcare.

The breakdown of primary participants is as mentioned below:

  • By Company Type: Tier 1 (45%), Tier 2 (30%), and Tier 3 (25%)
  • By Designation: Directors (42%), Managers (31%), and Others (27%)
  • By Region: North America (32%), Europe (26%), Asia Pacific (32%), the Middle East & Africa (5%), and Latin America (5%)

Key Players in the Quantum Computing in Healthcare Market

The key players operating in the quantum computing in healthcare market include Rigetti & Co, LLC (US), IBM (US), D-Wave Quantum Inc. (Canada), Microsoft (US), IonQ (US), Quantinuum, Ltd. (US & UK), Google, Inc. (US), Atos SE (France), QC Ware (California), Classiq Technologies, Inc. (US), Xanadu Quantum Technologies Inc. (Canada), Hefei Origin Quantum Computing Technology Co., Ltd. (China), Protiviti, Inc. (US), Quandela (France), Deloitte (UK), Accenture (Ireland), Amazon Web Services (AWS) (US), Fujitsu (Japan), Qnami (Switzerland), SEEQC (US), SandboxAQ (US), Pasqal (France), Qubit Pharmaceuticals (France), Polaris Quantum Biotech (US), and QSimulate (US).

Research Coverage

The report analyzes the quantum computing in healthcare market and estimates the market size and future growth potential of various market segments based on component, deployment, application, technology, end user, and region. It also provides a competitive analysis of the key players operating in this market, along with their company profiles, product offerings, recent developments, and key market strategies.

Reasons to Buy the Report

This report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share of the market. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their positions in the market.

This report provides insights on:

  • Analysis of key drivers (increasing investments in quantum computing in developed as well as emerging economies, growing inclination of payers toward quantum computing, rising demand for personalized medicine, increasing funding and investments in quantum computing startups, and rising need to reduce time and cost of drug discovery and development), restraints (accuracy issues with quantum computing systems and high implementation costs), opportunities (technological advancements in quantum computing supporting various healthcare applications and potential applications in medical image analysis and oncology), and challenges (lack of technical expertise & data management issues) influencing the growth of the quantum computing in healthcare market.
  • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the quantum computing in healthcare market.
  • Market Development: Comprehensive information on the lucrative emerging markets. The report analyzes the market for various types of quantum computing in healthcare solutions across regions.
  • Market Diversification: Exhaustive information about the product portfolios, growing geographies, recent developments, and investments in the quantum computing in healthcare market.
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, and capabilities of the leading players in the quantum computing in healthcare market, like Rigetti & Co, LLC (US), IBM (US), D-Wave Quantum Inc. (Canada), Microsoft (US), and IonQ (US).
Show more
Product Code: HIT 8642

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 STUDY SCOPE
    • 1.3.1 MARKET SEGMENTATION & REGIONAL SCOPE
    • 1.3.2 YEARS CONSIDERED
  • 1.4 CURRENCY CONSIDERED
  • 1.5 STAKEHOLDERS
  • 1.6 LIMITATIONS

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH APPROACH
    • 2.1.1 SECONDARY RESEARCH
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY RESEARCH
      • 2.1.2.1 Primary sources
      • 2.1.2.2 Key data from primary sources
      • 2.1.2.3 Breakdown of primaries
      • 2.1.2.4 Insights from primary experts
  • 2.2 RESEARCH METHODOLOGY DESIGN
  • 2.3 MARKET SIZE ESTIMATION
  • 2.4 MARKET BREAKDOWN & DATA TRIANGULATION
  • 2.5 MARKET SHARE ESTIMATION
  • 2.6 STUDY ASSUMPTIONS
  • 2.7 RESEARCH LIMITATIONS
    • 2.7.1 METHODOLOGY-RELATED LIMITATIONS
  • 2.8 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 OVERVIEW OF QUANTUM COMPUTING IN HEALTHCARE MARKET
  • 4.2 ASIA PACIFIC: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY COMPONENT
  • 4.3 GEOGRAPHIC SNAPSHOT OF QUANTUM COMPUTING IN HEALTHCARE MARKET
  • 4.4 REGIONAL MIX: QUANTUM COMPUTING IN HEALTHCARE MARKET
  • 4.5 QUANTUM COMPUTING IN HEALTHCARE MARKET: DEVELOPED VS. EMERGING ECONOMIES

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 MARKET DRIVERS
      • 5.2.1.1 Increasing investments in quantum computing in developed as well as emerging economies
      • 5.2.1.2 Growing inclination of payers toward quantum computing
      • 5.2.1.3 Rising demand for personalized medicine
      • 5.2.1.4 Increasing funding and investments in quantum computing startups
      • 5.2.1.5 Rising need to reduce time and cost of drug discovery and development
    • 5.2.2 MARKET RESTRAINTS
      • 5.2.2.1 Accuracy issues with quantum computing systems and high implementation costs
    • 5.2.3 MARKET OPPORTUNITIES
      • 5.2.3.1 Technological advancements in quantum computing for various healthcare applications
      • 5.2.3.2 Potential applications in medical image analysis and oncology
    • 5.2.4 MARKET CHALLENGES
      • 5.2.4.1 Lack of technical expertise and data management issues
  • 5.3 INDUSTRY TRENDS
    • 5.3.1 HYBRID QUANTUM-CLASSICAL COMPUTING
    • 5.3.2 QUANTUM MACHINE LEARNING
    • 5.3.3 GROWING NUMBER OF APPLICATIONS IN HEALTHCARE INDUSTRY
  • 5.4 TECHNOLOGY ANALYSIS
    • 5.4.1 KEY TECHNOLOGIES
      • 5.4.1.1 Artificial intelligence and machine learning integration
      • 5.4.1.2 Quantum communication technology
    • 5.4.2 COMPLEMENTARY TECHNOLOGIES
      • 5.4.2.1 Blockchain
      • 5.4.2.2 Digital twins
    • 5.4.3 ADJACENT TECHNOLOGIES
      • 5.4.3.1 Precision medicine
  • 5.5 PORTER'S FIVE FORCES ANALYSIS
    • 5.5.1 INTENSITY OF COMPETITIVE RIVALRY
    • 5.5.2 BARGAINING POWER OF SUPPLIERS
    • 5.5.3 BARGAINING POWER OF BUYERS
    • 5.5.4 THREAT OF NEW ENTRANTS
    • 5.5.5 THREAT OF SUBSTITUTES
  • 5.6 REGULATORY ANALYSIS
    • 5.6.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • 5.6.2 REGULATORY STANDARDS
      • 5.6.2.1 P1913 - Software-defined quantum communication
      • 5.6.2.2 P7130 - Standard for quantum technologies definitions
      • 5.6.2.3 P7131 - Standard for quantum computing performance metrics and benchmarking
  • 5.7 VALUE CHAIN ANALYSIS
    • 5.7.1 RESEARCH, DESIGN, AND DEVELOPMENT
    • 5.7.2 MANUFACTURERS & SERVICE PROVIDERS
    • 5.7.3 MARKETING & SALES EXECUTIVES
    • 5.7.4 END USERS
  • 5.8 ECOSYSTEM ANALYSIS
  • 5.9 PATENT ANALYSIS
    • 5.9.1 PATENT PUBLICATION TRENDS QUANTUM COMPUTING IN HEALTHCARE MARKET
    • 5.9.2 JURISDICTION AND TOP APPLICANT ANALYSIS
  • 5.10 CASE STUDY ANALYSIS
  • 5.11 KEY STAKEHOLDERS & BUYING CRITERIA
    • 5.11.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • 5.11.2 BUYING CRITERIA
  • 5.12 KEY CONFERENCES & EVENTS (2025-2026)
  • 5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • 5.14 IMPACT OF 2025 US TARIFF ON QUANTUM COMPUTING IN HEALTHCARE MARKET
    • 5.14.1 INTRODUCTION
    • 5.14.2 KEY TARIFF RATES
    • 5.14.3 PRICE IMPACT ANALYSIS
    • 5.14.4 IMPACT ON COUNTRY/REGION
      • 5.14.4.1 US
      • 5.14.4.2 Europe
      • 5.14.4.3 Asia Pacific
    • 5.14.5 IMPACT ON END USERS
      • 5.14.5.1 Pharmaceutical & biotechnology companies
      • 5.14.5.2 Labs & research institutes
      • 5.14.5.3 Healthcare providers
      • 5.14.5.4 Healthcare payers

6 QUANTUM COMPUTING IN HEALTHCARE MARKET, BY COMPONENT

  • 6.1 INTRODUCTION
  • 6.2 SOFTWARE
    • 6.2.1 SHIFT TO WEB/CLOUD-BASED MODELS TO SUPPORT GROWTH
  • 6.3 HARDWARE
    • 6.3.1 NEED FOR FREQUENT HARDWARE UPGRADES TO DRIVE MARKET GROWTH
  • 6.4 SERVICES
    • 6.4.1 INTRODUCTION OF COMPLEX SOFTWARE TO DRIVE DEMAND FOR SERVICES

7 QUANTUM COMPUTING IN HEALTHCARE MARKET, BY DEPLOYMENT

  • 7.1 INTRODUCTION
  • 7.2 ON-PREMISE SOLUTIONS
    • 7.2.1 RISING DEPLOYMENT OF ON-PREMISE QUANTUM COMPUTERS BY ORGANIZATIONS TO ENSURE DATA SECURITY
  • 7.3 CLOUD-BASED SOLUTIONS
    • 7.3.1 INCREASING PREFERENCE FOR CLOUD-BASED QUANTUM COMPUTING FOR RESEARCH & DEVELOPMENT TO SUPPORT MARKET GROWTH

8 QUANTUM COMPUTING IN HEALTHCARE MARKET, BY TECHNOLOGY

  • 8.1 INTRODUCTION
  • 8.2 SUPERCONDUCTING QUBITS
    • 8.2.1 LOW POWER CONSUMPTION, HIGH SPEED, AND ABILITY TO OPERATE AT LOW TEMPERATURES TO DRIVE MARKET
  • 8.3 TRAPPED IONS
    • 8.3.1 SUPERIOR CONNECTIVITY AND HIGHER GATE FIDELITY TO DRIVE MARKET
  • 8.4 QUANTUM ANNEALING
    • 8.4.1 QUICK DISCOVERY OF MOST EFFICIENT CONFIGURATIONS AMONG POSSIBLE COMBINATIONS OF VARIABLES TO DRIVE MARKET
  • 8.5 QUANTUM MACHINE LEARNING
    • 8.5.1 ABILITY OF QML TO ACCELERATE HEALTHCARE INNOVATION THROUGH NEXT-GEN INTELLIGENCE TO BOOST MARKET
  • 8.6 OTHER TECHNOLOGIES

9 QUANTUM COMPUTING IN HEALTHCARE MARKET, BY APPLICATION

  • 9.1 INTRODUCTION
  • 9.2 DRUG DISCOVERY & DEVELOPMENT
    • 9.2.1 ENABLING ACCURATE DATA PROJECTIONS AND SOLUTIONS FOR DRUG DISCOVERY AND DEVELOPMENT TO BOOST MARKET GROWTH
  • 9.3 MEDICAL DIAGNOSTICS
    • 9.3.1 PRECISE AND SENSITIVE MEDICAL DIAGNOSTIC PROCEDURES TO DRIVE MARKET
  • 9.4 GENOMICS & PRECISION MEDICINE
    • 9.4.1 UNLOCKING POWER OF GENOMICS & PRECISION MEDICINE WITH QUANTUM COMPUTING TECHNOLOGY TO SUPPORT MARKET GROWTH
  • 9.5 RADIOTHERAPY
    • 9.5.1 MORE PERSONALIZED AND PRECISE TREATMENT IN FIGHT AGAINST CANCER TO FUEL GROWTH
  • 9.6 RISK ANALYSIS
    • 9.6.1 ENHANCED PRICING MODEL MANAGEMENT AND DECREASED COSTS ASSOCIATED WITH FRAUD TO BOOST ADOPTION IN RISK ANALYSIS
  • 9.7 HEALTHCARE LOGISTICS & SCHEDULING
    • 9.7.1 ENHANCED OPERATIONAL EFFICIENCY AND REDUCED SCHEDULING BOTTLENECKS IN HEALTHCARE DELIVERY TO DRIVE DEMAND
  • 9.8 CYBERSECURITY & DATA ENCRYPTION
    • 9.8.1 SECURE PATIENT DATA WITH QUANTUM-RESISTANT ENCRYPTION AND ULTRA-SAFE COMMUNICATION PROTOCOLS TO PROPEL DEMAND
  • 9.9 OTHER APPLICATIONS

10 QUANTUM COMPUTING IN HEALTHCARE MARKET, BY END USER

  • 10.1 INTRODUCTION
  • 10.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
    • 10.2.1 RISING DEMAND FOR SOLUTIONS TO REDUCE TIME AND COSTS OF DRUG DEVELOPMENT TO DRIVE GROWTH
  • 10.3 LABS & RESEARCH INSTITUTES
    • 10.3.1 INCREASED RESEARCH ACTIVITIES TO ENCOURAGE USE OF AI IN GENOMICS IN ACADEMIC AND GOVERNMENT INSTITUTES
  • 10.4 HEALTHCARE PROVIDERS
    • 10.4.1 IMPROVED PATIENT MANAGEMENT, LOWERED COSTS, AND ABILITY TO DELIVER BETTER PATIENT TREATMENT TO BOOST DEMAND
  • 10.5 HEALTHCARE PAYERS
    • 10.5.1 POTENTIAL TO REDUCE READMISSIONS AND OVERHEAD COSTS TO DRIVE ADOPTION

11 QUANTUM COMPUTING IN HEALTHCARE MARKET, BY REGION

  • 11.1 INTRODUCTION
  • 11.2 NORTH AMERICA
    • 11.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
    • 11.2.2 US
      • 11.2.2.1 Expanding applications of quantum computing in healthcare to bolster market growth
    • 11.2.3 CANADA
      • 11.2.3.1 Investments and developments in quantum computing industry to drive market
  • 11.3 EUROPE
    • 11.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
    • 11.3.2 GERMANY
      • 11.3.2.1 Collaborations & partnerships to drive adoption of quantum computing solutions
    • 11.3.3 UK
      • 11.3.3.1 Increased focus on quantum computing applications to support growth
    • 11.3.4 FRANCE
      • 11.3.4.1 Government funding for quantum computing to bolster growth
    • 11.3.5 ITALY
      • 11.3.5.1 Advances in quantum healthcare with supercomputing integration and next-gen biomedical research to boost market
    • 11.3.6 SPAIN
      • 11.3.6.1 Strong government support to boost market in Spain
    • 11.3.7 REST OF EUROPE
  • 11.4 ASIA PACIFIC
    • 11.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
    • 11.4.2 JAPAN
      • 11.4.2.1 Rising penetration of technologies to support market growth
    • 11.4.3 CHINA
      • 11.4.3.1 China to dominate quantum computing in healthcare market in Asia Pacific
    • 11.4.4 INDIA
      • 11.4.4.1 Emerging real-world use cases to drive demand in India
    • 11.4.5 REST OF ASIA PACIFIC
  • 11.5 LATIN AMERICA
    • 11.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
    • 11.5.2 BRAZIL
      • 11.5.2.1 Rising adoption of quantum technologies to drive healthcare innovation in Brazil
    • 11.5.3 MEXICO
      • 11.5.3.1 Mexico to pave the way for quantum healthcare innovation
    • 11.5.4 REST OF LATIN AMERICA
  • 11.6 MIDDLE EAST & AFRICA
    • 11.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
    • 11.6.2 GCC COUNTRIES
      • 11.6.2.1 Advancing healthcare in GCC through quantum computing to drive growth
    • 11.6.3 REST OF MIDDLE EAST & AFRICA

12 COMPETITIVE LANDSCAPE

  • 12.1 OVERVIEW
  • 12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
    • 12.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN QUANTUM COMPUTING IN HEALTHCARE MARKET
  • 12.3 REVENUE ANALYSIS, 2020-2024
  • 12.4 MARKET SHARE ANALYSIS, 2024
  • 12.5 MARKET RANKING ANALYSIS
  • 12.6 COMPANY EVALUATION QUADRANT: KEY PLAYERS, 2024
    • 12.6.1 STARS
    • 12.6.2 EMERGING LEADERS
    • 12.6.3 PERVASIVE PLAYERS
    • 12.6.4 PARTICIPANTS
    • 12.6.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
      • 12.6.5.1 Company footprint
      • 12.6.5.2 Region footprint
      • 12.6.5.3 Component footprint
      • 12.6.5.4 Application footprint
      • 12.6.5.5 Technology footprint
      • 12.6.5.6 Deployment footprint
      • 12.6.5.7 End-user footprint
  • 12.7 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
    • 12.7.1 PROGRESSIVE COMPANIES
    • 12.7.2 RESPONSIVE COMPANIES
    • 12.7.3 DYNAMIC COMPANIES
    • 12.7.4 STARTING BLOCKS
    • 12.7.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
      • 12.7.5.1 Detailed list of key startups/SMEs
      • 12.7.5.2 Competitive benchmarking of startups/SMEs
  • 12.8 COMPANY VALUATION & FINANCIAL METRICS
    • 12.8.1 FINANCIAL METRICS
    • 12.8.2 COMPANY VALUATION
  • 12.9 BRAND/SOFTWARE COMPARISON
  • 12.10 COMPETITIVE SCENARIO
    • 12.10.1 PRODUCT & SERVICE LAUNCHES
    • 12.10.2 DEALS

13 COMPANY PROFILES

  • 13.1 KEY PLAYERS
    • 13.1.1 RIGETTI & CO, LLC.
      • 13.1.1.1 Business overview
      • 13.1.1.2 Products & services offered
      • 13.1.1.3 Recent developments
        • 13.1.1.3.1 Product launches
        • 13.1.1.3.2 Deals
        • 13.1.1.3.3 Other developments
      • 13.1.1.4 MnM view
        • 13.1.1.4.1 Key strengths
        • 13.1.1.4.2 Strategic choices
        • 13.1.1.4.3 Weaknesses & competitive threats
    • 13.1.2 IBM
      • 13.1.2.1 Business overview
      • 13.1.2.2 Products & services offered
      • 13.1.2.3 Recent developments
        • 13.1.2.3.1 Product launches
        • 13.1.2.3.2 Deals
      • 13.1.2.4 MnM view
        • 13.1.2.4.1 Key strengths
        • 13.1.2.4.2 Strategic choices
        • 13.1.2.4.3 Weaknesses & competitive threats
    • 13.1.3 D-WAVE QUANTUM INC.
      • 13.1.3.1 Business overview
      • 13.1.3.2 Products & services offered
      • 13.1.3.3 Recent developments
        • 13.1.3.3.1 Product launches
        • 13.1.3.3.2 Deals
      • 13.1.3.4 MnM view
        • 13.1.3.4.1 Key strengths
        • 13.1.3.4.2 Strategic choices
        • 13.1.3.4.3 Weaknesses & competitive threats
    • 13.1.4 MICROSOFT
      • 13.1.4.1 Business overview
      • 13.1.4.2 Products & services offered
      • 13.1.4.3 Recent developments
        • 13.1.4.3.1 Product launches
        • 13.1.4.3.2 Deals
      • 13.1.4.4 MnM view
        • 13.1.4.4.1 Key strengths
        • 13.1.4.4.2 Strategic choices
        • 13.1.4.4.3 Weaknesses & competitive threats
    • 13.1.5 IONQ
      • 13.1.5.1 Business overview
      • 13.1.5.2 Products & services offered
      • 13.1.5.3 Recent developments
        • 13.1.5.3.1 Product launches
        • 13.1.5.3.2 Deals
      • 13.1.5.4 MnM view
        • 13.1.5.4.1 Key strengths
        • 13.1.5.4.2 Strategic choices
        • 13.1.5.4.3 Weaknesses & competitive threats
    • 13.1.6 QUANTINUUM LTD.
      • 13.1.6.1 Business overview
      • 13.1.6.2 Products & services offered
      • 13.1.6.3 Recent developments
        • 13.1.6.3.1 Product launches
        • 13.1.6.3.2 Deals
    • 13.1.7 GOOGLE LLC
      • 13.1.7.1 Business overview
      • 13.1.7.2 Products & services offered
      • 13.1.7.3 Recent developments
        • 13.1.7.3.1 Product launches
        • 13.1.7.3.2 Deals
      • 13.1.7.4 MnM view
        • 13.1.7.4.1 Key strengths
        • 13.1.7.4.2 Strategic choices
        • 13.1.7.4.3 Weaknesses & competitive threats
    • 13.1.8 ATOS SE
      • 13.1.8.1 Business overview
      • 13.1.8.2 Products & services offered
      • 13.1.8.3 Recent developments
        • 13.1.8.3.1 Product launches
        • 13.1.8.3.2 Deals
    • 13.1.9 QC WARE
      • 13.1.9.1 Business overview
      • 13.1.9.2 Products & services offered
      • 13.1.9.3 Recent developments
        • 13.1.9.3.1 Product launches
        • 13.1.9.3.2 Deals
    • 13.1.10 CLASSIQ TECHNOLOGIES LTD.
      • 13.1.10.1 Business overview
      • 13.1.10.2 Products & services offered
      • 13.1.10.3 Recent developments
        • 13.1.10.3.1 Deals
    • 13.1.11 XANADU QUANTUM TECHNOLOGIES INC.
      • 13.1.11.1 Business overview
      • 13.1.11.2 Products & services offered
      • 13.1.11.3 Recent developments
        • 13.1.11.3.1 Product launches
        • 13.1.11.3.2 Deals
    • 13.1.12 HEFEI ORIGIN QUANTUM COMPUTING TECHNOLOGY CO., LTD.
      • 13.1.12.1 Business overview
      • 13.1.12.2 Products & services offered
      • 13.1.12.3 Recent developments
        • 13.1.12.3.1 Product launches
        • 13.1.12.3.2 Deals
    • 13.1.13 PROTIVITI INC.
      • 13.1.13.1 Business overview
      • 13.1.13.2 Products & services offered
    • 13.1.14 QUANDELA
      • 13.1.14.1 Business overview
      • 13.1.14.2 Products & services offered
      • 13.1.14.3 Recent developments
        • 13.1.14.3.1 Product launches
        • 13.1.14.3.2 Deals
    • 13.1.15 DELOITTE
      • 13.1.15.1 Business overview
      • 13.1.15.2 Products & services offered
      • 13.1.15.3 Recent developments
        • 13.1.15.3.1 Deals
    • 13.1.16 ACCENTURE
      • 13.1.16.1 Business overview
      • 13.1.16.2 Products & services offered
      • 13.1.16.3 Recent developments
        • 13.1.16.3.1 Deals
    • 13.1.17 AMAZON WEB SERVICES (AWS)
      • 13.1.17.1 Business overview
      • 13.1.17.2 Products & services offered
      • 13.1.17.3 Recent developments
        • 13.1.17.3.1 Product & service launches
        • 13.1.17.3.2 Deals
      • 13.1.17.4 MnM view
        • 13.1.17.4.1 Key strengths
        • 13.1.17.4.2 Strategic choices
        • 13.1.17.4.3 Weaknesses & competitive threats
    • 13.1.18 FUJITSU
      • 13.1.18.1 Business overview
      • 13.1.18.2 Product & services offered
      • 13.1.18.3 Recent developments
        • 13.1.18.3.1 Product launches
        • 13.1.18.3.2 Deals
    • 13.1.19 QNAMI
      • 13.1.19.1 Business overview
      • 13.1.19.2 Products & services offered
      • 13.1.19.3 Recent developments
        • 13.1.19.3.1 Product launches
        • 13.1.19.3.2 Deals
        • 13.1.19.3.3 Expansions
    • 13.1.20 SEEQC
      • 13.1.20.1 Business overview
      • 13.1.20.2 Product & services offered
      • 13.1.20.3 Recent developments
        • 13.1.20.3.1 Product launches
        • 13.1.20.3.2 Deals
  • 13.2 OTHER PLAYERS
    • 13.2.1 SANDBOX AQ
    • 13.2.2 PASQAL
    • 13.2.3 QUBIT PHARMACEUTICALS
    • 13.2.4 POLARIS QUANTUM BIOTECH
    • 13.2.5 QSIMULATE

14 APPENDIX

  • 14.1 DISCUSSION GUIDE
  • 14.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 14.3 CUSTOMIZATION OPTIONS
  • 14.4 RELATED REPORTS
  • 14.5 AUTHOR DETAILS
Show more
Product Code: HIT 8642

List of Tables

  • TABLE 1 INCLUSIONS & EXCLUSIONS
  • TABLE 2 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD
  • TABLE 3 RISK ASSESSMENT: QUANTUM COMPUTING IN HEALTHCARE MARKET
  • TABLE 4 MARKET DYNAMICS: QUANTUM COMPUTING IN HEALTHCARE MARKET
  • TABLE 5 LIST OF QUANTUM COMPUTING STARTUPS
  • TABLE 6 QUANTUM COMPUTING IN HEALTHCARE MARKET: PORTER'S FIVE FORCES ANALYSIS
  • TABLE 7 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 8 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 9 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 10 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 11 QUANTUM COMPUTING IN HEALTHCARE MARKET: LIST OF PATENTS/ PATENT APPLICATIONS, 2022-2025
  • TABLE 12 CASE STUDY 1: MENTEN AI LEVERAGED D-WAVE QUANTUM COMPUTING PRODUCTS TO BATTLE COVID-19 WITH QUANTUM PEPTIDE THERAPEUTICS
  • TABLE 13 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS (%)
  • TABLE 14 KEY BUYING CRITERIA FOR QUANTUM COMPUTING COMPONENTS
  • TABLE 15 US-ADJUSTED RECIPROCAL TARIFF RATES
  • TABLE 16 QUANTUM COMPUTING IN HEALTHCARE MARKET, BY COMPONENT, 2023-2030 (USD MILLION)
  • TABLE 17 QUANTUM COMPUTING IN HEALTHCARE SOFTWARE OFFERED BY KEY MARKET PLAYERS
  • TABLE 18 QUANTUM COMPUTING IN HEALTHCARE SOFTWARE MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 19 QUANTUM COMPUTING IN HEALTHCARE HARDWARE MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 20 QUANTUM COMPUTING IN HEALTHCARE SERVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 21 QUANTUM COMPUTING IN HEALTHCARE MARKET, BY DEPLOYMENT, 2023-2030 (USD MILLION)
  • TABLE 22 QUANTUM COMPUTING IN HEALTHCARE MARKET FOR ON-PREMISE SOLUTIONS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 23 QUANTUM COMPUTING IN HEALTHCARE MARKET FOR CLOUD-BASED SOLUTIONS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 24 QUANTUM COMPUTING IN HEALTHCARE MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 25 QUANTUM COMPUTING IN HEALTHCARE MARKET FOR SUPERCONDUCTING QUBITS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 26 QUANTUM COMPUTING IN HEALTHCARE MARKET FOR TRAPPED IONS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 27 QUANTUM COMPUTING IN HEALTHCARE MARKET FOR QUANTUM ANNEALING, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 28 QUANTUM COMPUTING IN HEALTHCARE MARKET FOR QUANTUM MACHINE LEARNING, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 29 QUANTUM COMPUTING IN HEALTHCARE MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 30 QUANTUM COMPUTING IN HEALTHCARE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 31 QUANTUM COMPUTING IN HEALTHCARE MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 32 QUANTUM COMPUTING IN HEALTHCARE MARKET FOR MEDICAL DIAGNOSTICS APPLICATIONS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 33 QUANTUM COMPUTING IN HEALTHCARE MARKET FOR GENOMICS & PRECISION MEDICINE APPLICATIONS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 34 QUANTUM COMPUTING IN HEALTHCARE MARKET FOR RADIOTHERAPY APPLICATIONS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 35 QUANTUM COMPUTING IN HEALTHCARE MARKET FOR RISK ANALYSIS APPLICATIONS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 36 QUANTUM COMPUTING IN HEALTHCARE MARKET FOR HEALTHCARE LOGISTICS & SCHEDULING APPLICATIONS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 37 QUANTUM COMPUTING IN HEALTHCARE MARKET FOR CYBERSECURITY & DATA ENCRYPTION APPLICATIONS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 38 QUANTUM COMPUTING IN HEALTHCARE MARKET OTHER APPLICATIONS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 39 QUANTUM COMPUTING IN HEALTHCARE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 40 QUANTUM COMPUTING IN HEALTHCARE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 41 QUANTUM COMPUTING IN HEALTHCARE MARKET FOR LABS & RESEARCH INSTITUTES, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 42 QUANTUM COMPUTING IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 43 QUANTUM COMPUTING IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 44 QUANTUM COMPUTING IN HEALTHCARE MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 45 NORTH AMERICA: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 46 NORTH AMERICA: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY COMPONENT, 2023-2030 (USD MILLION)
  • TABLE 47 NORTH AMERICA: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY DEPLOYMENT, 2023-2030 (USD MILLION)
  • TABLE 48 NORTH AMERICA: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 49 NORTH AMERICA: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 50 NORTH AMERICA: QUANTUM COMPUTING IN MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 51 US: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY COMPONENT, 2023-2030 (USD MILLION)
  • TABLE 52 US: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY DEPLOYMENT, 2023-2030 (USD MILLION)
  • TABLE 53 US: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 54 US: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 55 US: QUANTUM COMPUTING IN MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 56 CANADA: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY COMPONENT, 2023-2030 (USD MILLION)
  • TABLE 57 CANADA: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY DEPLOYMENT, 2023-2030 (USD MILLION)
  • TABLE 58 CANADA: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 59 CANADA: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 60 CANADA: QUANTUM COMPUTING IN MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 61 EUROPE: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 62 EUROPE: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY COMPONENT, 2023-2030 (USD MILLION)
  • TABLE 63 EUROPE: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY DEPLOYMENT, 2023-2030 (USD MILLION)
  • TABLE 64 EUROPE: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 65 EUROPE: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 66 EUROPE: QUANTUM COMPUTING IN MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 67 GERMANY: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY COMPONENT, 2023-2030 (USD MILLION)
  • TABLE 68 GERMANY: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY DEPLOYMENT, 2023-2030 (USD MILLION)
  • TABLE 69 GERMANY: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 70 GERMANY: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 71 GERMANY: QUANTUM COMPUTING IN MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 72 UK: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY COMPONENT, 2023-2030 (USD MILLION)
  • TABLE 73 UK: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY DEPLOYMENT, 2023-2030 (USD MILLION)
  • TABLE 74 UK: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 75 UK: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 76 UK: QUANTUM COMPUTING IN MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 77 FRANCE: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY COMPONENT, 2023-2030 (USD MILLION)
  • TABLE 78 FRANCE: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY DEPLOYMENT, 2023-2030 (USD MILLION)
  • TABLE 79 FRANCE: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 80 FRANCE: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 81 FRANCE: QUANTUM COMPUTING IN MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 82 ITALY: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY COMPONENT, 2023-2030 (USD MILLION)
  • TABLE 83 ITALY: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY DEPLOYMENT, 2023-2030 (USD MILLION)
  • TABLE 84 ITALY: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 85 ITALY: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 86 ITALY: QUANTUM COMPUTING IN MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 87 SPAIN: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY COMPONENT, 2023-2030 (USD MILLION)
  • TABLE 88 SPAIN: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY DEPLOYMENT, 2023-2030 (USD MILLION)
  • TABLE 89 SPAIN: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 90 SPAIN: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 91 SPAIN: QUANTUM COMPUTING IN MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 92 REST OF EUROPE: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY COMPONENT, 2023-2030 (USD MILLION)
  • TABLE 93 REST OF EUROPE: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY DEPLOYMENT, 2023-2030 (USD MILLION)
  • TABLE 94 REST OF EUROPE: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 95 REST OF EUROPE: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 96 REST OF EUROPE: QUANTUM COMPUTING IN MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 97 ASIA PACIFIC: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 98 ASIA PACIFIC: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY COMPONENT, 2023-2030 (USD MILLION)
  • TABLE 99 ASIA PACIFIC: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY DEPLOYMENT, 2023-2030 (USD MILLION)
  • TABLE 100 ASIA PACIFIC: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 101 ASIA PACIFIC: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 102 ASIA PACIFIC: QUANTUM COMPUTING IN MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 103 JAPAN: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY COMPONENT, 2023-2030 (USD MILLION)
  • TABLE 104 JAPAN: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY DEPLOYMENT, 2023-2030 (USD MILLION)
  • TABLE 105 JAPAN: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 106 JAPAN: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 107 JAPAN: QUANTUM COMPUTING IN MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 108 CHINA: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY COMPONENT, 2023-2030 (USD MILLION)
  • TABLE 109 CHINA: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY DEPLOYMENT, 2023-2030 (USD MILLION)
  • TABLE 110 CHINA: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 111 CHINA: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 112 CHINA: QUANTUM COMPUTING IN MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 113 INDIA: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY COMPONENT, 2023-2030 (USD MILLION)
  • TABLE 114 INDIA: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY DEPLOYMENT, 2023-2030 (USD MILLION)
  • TABLE 115 INDIA: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 116 INDIA: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 117 INDIA: QUANTUM COMPUTING IN MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 118 REST OF ASIA PACIFIC: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY COMPONENT, 2023-2030 (USD MILLION)
  • TABLE 119 REST OF ASIA PACIFIC: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY DEPLOYMENT, 2023-2030 (USD MILLION)
  • TABLE 120 REST OF ASIA PACIFIC: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 121 REST OF ASIA PACIFIC: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 122 REST OF ASIA PACIFIC: QUANTUM COMPUTING IN MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 123 LATIN AMERICA: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 124 LATIN AMERICA: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY COMPONENT, 2023-2030 (USD MILLION)
  • TABLE 125 LATIN AMERICA: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY DEPLOYMENT, 2023-2030 (USD MILLION)
  • TABLE 126 LATIN AMERICA: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 127 LATIN AMERICA: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 128 LATIN AMERICA: QUANTUM COMPUTING IN MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 129 BRAZIL: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY COMPONENT, 2023-2030 (USD MILLION)
  • TABLE 130 BRAZIL: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY DEPLOYMENT, 2023-2030 (USD MILLION)
  • TABLE 131 BRAZIL: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 132 BRAZIL: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 133 BRAZIL: QUANTUM COMPUTING IN MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 134 MEXICO: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY COMPONENT, 2023-2030 (USD MILLION)
  • TABLE 135 MEXICO: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY DEPLOYMENT, 2023-2030 (USD MILLION)
  • TABLE 136 MEXICO: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 137 MEXICO: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 138 MEXICO: QUANTUM COMPUTING IN MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 139 REST OF LATIN AMERICA: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY COMPONENT, 2023-2030 (USD MILLION)
  • TABLE 140 REST OF LATIN AMERICA: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY DEPLOYMENT, 2023-2030 (USD MILLION)
  • TABLE 141 REST OF LATIN AMERICA: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 142 REST OF LATIN AMERICA: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 143 REST OF LATIN AMERICA: QUANTUM COMPUTING IN MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 144 MIDDLE EAST & AFRICA: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 145 MIDDLE EAST & AFRICA: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY COMPONENT, 2023-2030 (USD MILLION)
  • TABLE 146 MIDDLE EAST & AFRICA: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY DEPLOYMENT, 2023-2030 (USD MILLION)
  • TABLE 147 MIDDLE EAST & AFRICA: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 148 MIDDLE EAST & AFRICA: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 149 MIDDLE EAST & AFRICA: QUANTUM COMPUTING IN MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 150 GCC COUNTRIES: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY COMPONENT, 2023-2030 (USD MILLION)
  • TABLE 151 GCC COUNTRIES: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY DEPLOYMENT, 2023-2030 (USD MILLION)
  • TABLE 152 GCC COUNTRIES: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 153 GCC COUNTRIES: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 154 GCC COUNTRIES: QUANTUM COMPUTING IN MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 155 REST OF MIDDLE EAST & AFRICA: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY COMPONENT, 2023-2030 (USD MILLION)
  • TABLE 156 REST OF MIDDLE EAST & AFRICA: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY DEPLOYMENT, 2023-2030 (USD MILLION)
  • TABLE 157 REST OF MIDDLE EAST & AFRICA: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
  • TABLE 158 REST OF MIDDLE EAST & AFRICA: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 159 REST OF MIDDLE EAST & AFRICA: QUANTUM COMPUTING IN MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 160 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN QUANTUM COMPUTING IN HEALTHCARE, JANUARY 2022-MAY 2025
  • TABLE 161 QUANTUM COMPUTING IN HEALTHCARE MARKET: DEGREE OF COMPETITION
  • TABLE 162 QUANTUM COMPUTING IN HEALTHCARE MARKET: REGION FOOTPRINT
  • TABLE 163 QUANTUM COMPUTING IN HEALTHCARE MARKET: COMPONENT FOOTPRINT
  • TABLE 164 QUANTUM COMPUTING IN HEALTHCARE MARKET: APPLICATION FOOTPRINT
  • TABLE 165 QUANTUM COMPUTING IN HEALTHCARE MARKET: TECHNOLOGY FOOTPRINT
  • TABLE 166 QUANTUM COMPUTING IN HEALTHCARE MARKET: DEPLOYMENT FOOTPRINT
  • TABLE 167 QUANTUM COMPUTING IN HEALTHCARE MARKET: END-USER FOOTPRINT
  • TABLE 168 QUANTUM COMPUTING IN HEALTHCARE MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS
  • TABLE 169 QUANTUM COMPUTING IN HEALTHCARE MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS, BY REGION
  • TABLE 170 QUANTUM COMPUTING IN HEALTHCARE MARKET: PRODUCT & SERVICE LAUNCHES, JANUARY 2022-MAY 2025
  • TABLE 171 QUANTUM COMPUTING IN HEALTHCARE MARKET: DEALS, JANUARY 2022-MAY 2025
  • TABLE 172 RIGETTI & CO, LLC.: COMPANY OVERVIEW
  • TABLE 173 RIGETTI & CO, LLC.: PRODUCTS & SERVICES OFFERED
  • TABLE 174 RIGETTI & CO, LLC.: PRODUCT LAUNCHES, JANUARY 2022-MAY 2025
  • TABLE 175 RIGETTI & CO, LLC.: DEALS, JANUARY 2022-MAY 2025
  • TABLE 176 RIGETTI & CO, LLC.: OTHER DEVELOPMENTS, JANUARY 2021-MARCH 2024
  • TABLE 177 IBM: COMPANY OVERVIEW
  • TABLE 178 IBM: PRODUCTS & SERVICES OFFERED
  • TABLE 179 IBM: PRODUCT LAUNCHES, JANUARY 2022-MAY 2025
  • TABLE 180 IBM: DEALS, JANUARY 2022-MAY 2025
  • TABLE 181 D-WAVE QUANTUM INC.: COMPANY OVERVIEW
  • TABLE 182 D-WAVE QUANTUM INC: PRODUCTS & SERVICES OFFERED
  • TABLE 183 D-WAVE QUANTUM INC: PRODUCT LAUNCHES, JANUARY 2022-MAY 2025
  • TABLE 184 D-WAVE QUANTUM INC.: DEALS, JANUARY 2022-MAY 2025
  • TABLE 185 MICROSOFT: COMPANY OVERVIEW
  • TABLE 186 MICROSOFT: PRODUCTS & SERVICES OFFERED
  • TABLE 187 MICROSOFT: PRODUCT LAUNCHES, JANUARY 2022-MAY 2025
  • TABLE 188 MICROSOFT: DEALS, JANUARY 2022-MAY 2025
  • TABLE 189 IONQ: COMPANY OVERVIEW
  • TABLE 190 IONQ: PRODUCTS & SERVICES OFFERED
  • TABLE 191 IONQ: PRODUCT LAUNCHES, JANUARY 2022-MAY 2025
  • TABLE 192 IONQ: DEALS, JANUARY 2022-MAY 2025
  • TABLE 193 QUANTINUUM LTD.: COMPANY OVERVIEW
  • TABLE 194 QUANTINUUM LTD.: PRODUCTS & SERVICES OFFERED
  • TABLE 195 QUANTINUUM LTD.: PRODUCT LAUNCHES, JANUARY 2022-MAY 2025
  • TABLE 196 QUANTINUUM LTD.: DEALS, JANUARY 2022-MAY 2025
  • TABLE 197 GOOGLE LLC: COMPANY OVERVIEW
  • TABLE 198 GOOGLE LLC: PRODUCTS & SERVICES OFFERED
  • TABLE 199 GOOGLE LLC: PRODUCT LAUNCHES, JANUARY 2022-MAY 2025
  • TABLE 201 GOOGLE LLC: DEALS, JANUARY 2022-MAY 2025
  • TABLE 202 ATOS SE: COMPANY OVERVIEW
  • TABLE 203 ATOS SE: PRODUCTS & SERVICES OFFERED
  • TABLE 204 ATOS SE: PRODUCT LAUNCHES, JANUARY 2022-MAY 2025
  • TABLE 205 ATOS SE: DEALS, JANUARY 2022-MAY 2025
  • TABLE 206 QC WARE: COMPANY OVERVIEW
  • TABLE 207 QC WARE: PRODUCTS & SERVICES OFFERED
  • TABLE 208 QC WARE: PRODUCT LAUNCHES, JANUARY 2022-MAY 2025
  • TABLE 209 QC WARE: DEALS, JANUARY 2022-MAY 2025
  • TABLE 210 CLASSIQ TECHNOLOGIES LTD.: COMPANY OVERVIEW
  • TABLE 211 CLASSIQ TECHNOLOGIES LTD.: PRODUCTS & SERVICES OFFERED
  • TABLE 212 CLASSIQ TECHNOLOGIES LTD.: DEALS, JANUARY 2022-MAY 2025
  • TABLE 213 XANADU QUANTUM TECHNOLOGIES INC.: COMPANY OVERVIEW
  • TABLE 214 XANADU QUANTUM TECHNOLOGIES INC.: PRODUCTS & SERVICES OFFERED
  • TABLE 215 XANADU QUANTUM TECHNOLOGIES INC.: PRODUCT LAUNCHES, JANUARY 2022-MAY 2025
  • TABLE 216 XANADU QUANTUM TECHNOLOGIES INC.: DEALS, JANUARY 2022-MAY 2025
  • TABLE 217 HEFEI ORIGIN QUANTUM COMPUTING TECHNOLOGY CO., LTD.: COMPANY OVERVIEW
  • TABLE 218 HEFEI ORIGIN QUANTUM COMPUTING TECHNOLOGY CO., LTD.: PRODUCTS & SERVICES OFFERED
  • TABLE 219 HEFEI ORIGIN QUANTUM COMPUTING TECHNOLOGY CO., LTD.: PRODUCT LAUNCHES, JANUARY 2022-MAY 2025
  • TABLE 220 HEFEI ORIGIN QUANTUM COMPUTING TECHNOLOGY CO., LTD.: DEALS, JANUARY 2022-MAY 2025
  • TABLE 221 PROTIVITI INC.: COMPANY OVERVIEW
  • TABLE 222 PROTIVITI INC.: PRODUCTS & SERVICES OFFERED
  • TABLE 223 QUANDELA: COMPANY OVERVIEW
  • TABLE 224 QUANDELA: PRODUCTS & SERVICES OFFERED
  • TABLE 225 QUANDELA: PRODUCT LAUNCHES, JANUARY 2022-MAY 2025
  • TABLE 226 QUANDELA: DEALS, JANUARY 2022-MAY 2025
  • TABLE 227 DELOITTE: COMPANY OVERVIEW
  • TABLE 228 DELOITTE: PRODUCTS & SERVICES OFFERED
  • TABLE 229 DELOITTE: DEALS, JANUARY 2022-MAY 2025
  • TABLE 230 ACCENTURE: COMPANY OVERVIEW
  • TABLE 231 ACCENTURE: PRODUCTS & SERVICES OFFERED
  • TABLE 232 ACCENTURE: DEALS, JANUARY 2022-MAY 2025
  • TABLE 233 AMAZON WEB SERVICES (AWS): COMPANY OVERVIEW
  • TABLE 234 AMAZON WEB SERVICES (AWS): PRODUCTS & SERVICES OFFERED
  • TABLE 235 AMAZON WEB SERVICES (AWS): PRODUCT & SERVICE LAUNCHES, JANUARY 2022-MAY 2025
  • TABLE 236 AMAZON WEB SERVICES (AWS): DEALS, JANUARY 2022-MAY 2025
  • TABLE 237 FUJITSU: COMPANY OVERVIEW
  • TABLE 238 FUJITSU: PRODUCTS & SERVICES OFFERED
  • TABLE 239 FUJITSU: PRODUCT LAUNCHES, JANUARY 2022-MAY 2025
  • TABLE 240 FUJITSU: DEALS, JANUARY 2022-MAY 2025
  • TABLE 241 QNAMI: COMPANY OVERVIEW
  • TABLE 242 QNAMI: PRODUCTS & SERVICES OFFERED
  • TABLE 243 QNAMI: PRODUCT LAUNCHES, JANUARY 2022-MAY 2025
  • TABLE 244 QNAMI: DEALS, JANUARY 2022-MAY 2025
  • TABLE 245 QNAMI: EXPANSIONS, JANUARY 2022-MAY 2025
  • TABLE 246 SEEQC: COMPANY OVERVIEW
  • TABLE 247 SEEQC: PRODUCTS & SERVICES OFFERED
  • TABLE 248 SEEQC: PRODUCT LAUNCHES, JANUARY 2022-MAY 2025
  • TABLE 249 SEEQC: DEALS, JANUARY 2022-MAY 2025

List of Figures

  • FIGURE 1 QUANTUM COMPUTING IN HEALTHCARE MARKET SEGMENTATION & REGIONAL SCOPE
  • FIGURE 2 RESEARCH DESIGN
  • FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 1 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
  • FIGURE 2 BOTTOM-UP APPROACH
  • FIGURE 3 TOP-DOWN APPROACH
  • FIGURE 4 CAGR PROJECTIONS FROM ANALYSIS OF MARKET DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF QUANTUM COMPUTING IN HEALTHCARE INDUSTRY
  • FIGURE 5 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
  • FIGURE 6 DATA TRIANGULATION METHODOLOGY
  • FIGURE 7 QUANTUM COMPUTING IN HEALTHCARE MARKET, BY COMPONENT, 2025 VS. 2030 (USD MILLION)
  • FIGURE 8 QUANTUM COMPUTING IN HEALTHCARE MARKET, BY DEPLOYMENT, 2025 VS. 2030 (USD MILLION)
  • FIGURE 9 QUANTUM COMPUTING IN HEALTHCARE MARKET, BY TECHNOLOGY, 2025 VS. 2030 (USD MILLION)
  • FIGURE 10 QUANTUM COMPUTING IN HEALTHCARE MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION)
  • FIGURE 11 QUANTUM COMPUTING IN HEALTHCARE MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
  • FIGURE 12 QUANTUM COMPUTING IN HEALTHCARE MARKET: REGIONAL SNAPSHOT
  • FIGURE 13 GOVERNMENT SUPPORT FOR ADOPTION OF QUANTUM COMPUTING TO DRIVE MARKET GROWTH
  • FIGURE 14 HARDWARE SEGMENT AND CHINA TO COMMAND LARGEST SHARES OF ASIA PACIFIC MARKET IN 2024
  • FIGURE 15 MARKET IN CHINA TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
  • FIGURE 16 ASIA PACIFIC TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD
  • FIGURE 17 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD
  • FIGURE 18 QUANTUM COMPUTING IN HEALTHCARE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 19 QUANTUM COMPUTING IN HEALTHCARE MARKET: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 20 QUANTUM COMPUTING IN HEALTHCARE MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 21 QUANTUM COMPUTING IN HEALTHCARE MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 22 PATENT PUBLICATION TRENDS, JANUARY 2015-MAY 2025
  • FIGURE 23 TOP PATENT APPLICANTS AND OWNERS (COMPANIES/INSTITUTIONS) FOR QUANTUM COMPUTING IN HEALTHCARE MARKET, JANUARY 2012-MAY 2025
  • FIGURE 24 TOP APPLICANT COUNTRIES/JURISDICTIONS FOR QUANTUM COMPUTING IN HEALTHCARE PATENTS, JANUARY 2015-MAY 2025
  • FIGURE 25 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS
  • FIGURE 26 KEY BUYING CRITERIA FOR QUANTUM COMPUTING COMPONENTS
  • FIGURE 27 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • FIGURE 28 NORTH AMERICA: QUANTUM COMPUTING IN HEALTHCARE MARKET SNAPSHOT
  • FIGURE 29 ASIA PACIFIC: QUANTUM COMPUTING IN HEALTHCARE SNAPSHOT 2024
  • FIGURE 30 REVENUE ANALYSIS OF KEY PLAYERS IN QUANTUM COMPUTING IN HEALTHCARE MARKET, 2020-2024
  • FIGURE 31 MARKET SHARE ANALYSIS OF KEY PLAYERS IN QUANTUM COMPUTING IN HEALTHCARE MARKET, 2024
  • FIGURE 32 QUANTUM COMPUTING IN HEALTHCARE MARKET RANKING ANALYSIS, BY PLAYER, 2024
  • FIGURE 33 QUANTUM COMPUTING IN HEALTHCARE MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
  • FIGURE 34 QUANTUM COMPUTING IN HEALTHCARE MARKET: COMPANY FOOTPRINT
  • FIGURE 35 QUANTUM COMPUTING IN HEALTHCARE MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
  • FIGURE 36 EV/EBITDA OF KEY VENDORS
  • FIGURE 37 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 38 QUANTUM COMPUTING IN HEALTHCARE MARKET: BRAND/SOFTWARE COMPARATIVE ANALYSIS
  • FIGURE 39 RIGETTI & CO, LLC.: COMPANY SNAPSHOT (2024)
  • FIGURE 40 IBM: COMPANY SNAPSHOT (2024)
  • FIGURE 41 D-WAVE QUANTUM INC.: COMPANY SNAPSHOT (2024)
  • FIGURE 42 MICROSOFT: COMPANY SNAPSHOT (2024)
  • FIGURE 43 IONQ: COMPANY SNAPSHOT (2024)
  • FIGURE 44 GOOGLE LLC: COMPANY SNAPSHOT (2024)
  • FIGURE 45 ATOS SE: COMPANY SNAPSHOT (2024)
  • FIGURE 46 PROTIVITI INC.: COMPANY SNAPSHOT (2024)
  • FIGURE 47 ACCENTURE: COMPANY SNAPSHOT (2024)
  • FIGURE 48 AMAZON WEB SERVICES (AWS): COMPANY SNAPSHOT (2024)
  • FIGURE 49 FUJITSU: COMPANY SNAPSHOT (2024)
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!